Search results
Wegovy, an injectable medication used to treat obesity, will now be available in Canada. Here's what...
Yahoo Canada Style· 9 hours agoPerspectives Wegovy users are advised to modify their diet and exercise. (Image via Getty Images)...
What Is 'Ozempic Face'? Here's Everything You Need to Know About This Common Phenomenon
Parade· 5 hours agoIs Ozempic face aging actually a thing? It seems the pop culture and social media narrative...
'Good Morning America' Anchor Dr. Jennifer Ashton Quits ABC After 13 Years
popculture.com· 12 hours agoAshton announced the launch of Ajenda in March, and in April she gave a statement to The Hollywood...
Coalition urges DoD to tackle obesity epidemic
Federal News Network· 9 hours agoTom Temin And in this letter to Secretary Austin, you’re saying that obesity is an existential threat to the U.S. military. Courtney Manning...
Amgen axes obesity asset after phase 1 results, zooms in on MariTide
FierceBiotech· 6 hours agoAmgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. “Given the...
This Is Why You’re Not Losing Weight on Semaglutide + Doctors’ Tips To Speed Results
Woman's World via Yahoo News· 17 hours ago“Not everyone responds to GLP-1 drugs, and we are not sure why just yet,” says Mert Erogul, MD, an ...
Amgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Investor's Business Daily· 5 hours agoThe company didn't provide any numbers from its study of MariTide in adults with obesity. This puts Amgen on track to potentially rival blockbuster weight-loss drugs from ...
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Amgen Inc.’s shares soared in late trading after its chief executive officer said he...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
WKBN 27 Youngstown· 17 hours agoFood and Drug Administration (FDA) has completed its 30-day review of the investigational new drug (IND) application for the use of bremelanotide, a melanocortin receptor 4 agonist (MCR4), for ...
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks
InvestorPlace· 5 hours agoAccording to Harvard University, about two-thirds of United States adults are “overweight or obese,”...